CP and hepatocellular carcinoma: However, comparing with N-CP, the symptoms score in QLQ-C30 was only lower at M1 and M3 by MDT-CP, but there was no difference at M6, which might be because MDT-CP could promote the recovery of patients after surgery in a short time; but with the increase of time, the symptoms of HCC patients in N-CP group were also relieved.